TYL vs WST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
WST Captures Institutional Edge (2โ2 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to West Pharmaceutical Services, Inc. (WST) driven by superior Growth & Margin, Momentum & Technical while TYL counters with relative strength in Valuation, Options & Structure. Fundamentally, TYL trades at 27.4x Forward P/E with 15.7% operating margin (+8.7% YoY revenue) versus WST at 40.2x Forward P/E and 22.9% operating margin (+8.7% YoY). In options structure, TYL sits in BREAKOUT (22nd %ile IV; Dealer Gamma Walls on Pro) against WST sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TYL Revenue | WST Revenue | TYL Op. Margin | WST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $940M | $1.72B | 16.3% | 14.0% | TYL |
| FY2019 | $1.09B | $1.84B | 14.4% | 16.1% | WST |
| FY2020 | $1.12B | $2.15B | 15.5% | 19.0% | WST |
| FY2021 | $1.59B | $2.83B | 11.4% | 26.6% | WST |
| FY2022 | $1.85B | $2.89B | 11.6% | 25.4% | WST |
| FY2023 | $1.95B | $2.95B | 11.2% | 22.9% | WST |
| FY2024 | $2.14B | $2.89B | 14.0% | 19.7% | WST |
| FY2025 | $2.33B | $3.07B | 15.3% | 19.0% | WST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TYL | WST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $16.9B | $29.0B | Larger Scale | WST |
| Trailing P/E Ratio Valuation | 52.9x | 46.7x | Lower Multiple | WST |
| Forward P/E Ratio Valuation | 27.4x | 40.2x | Lower Multiple | TYL |
| Revenue Growth (YoY) Growth | +8.7% | +8.7% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 15.7% | 22.9% | Higher Margin | WST |
| Net Profit Margin Profitability | 13.5% | 18.8% | Higher Margin | WST |
| Return on Equity (ROE) Capital Efficiency | 10.5% | 21.2% | Higher ROE | WST |
| 52-Week Range Position Momentum | 68% ($271โ$482) | 88% ($224โ$438) | Stronger Trend | WST |
| Beta / 30D Volatility Risk Regime | -0.39ฮฒ ยท 42% Vol | 0.46ฮฒ ยท 24% Vol | Lower Realized Risk | WST |
| Unified Institutional Score Composite Signal | 40.4 / 100 (SELL) | 39.8 / 100 (SELL) | Higher Composite | TYL |